BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30074510)

  • 21. Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features.
    Brady S; Squier W; Hilton-Jones D
    J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1240-6. PubMed ID: 23864699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the accuracy of neuromuscular ultrasound for inclusion body myositis.
    Karvelas KR; Xiao T; Langefeld CD; Walker FO; Pathak S; Caress JB; Baute V; Cartwright MS
    Muscle Nerve; 2019 Apr; 59(4):478-481. PubMed ID: 30635914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis and therapy of inclusion body myositis.
    Greenberg SA
    Curr Opin Neurol; 2012 Oct; 25(5):630-9. PubMed ID: 22941263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inclusion body myositis.
    Greenberg SA
    Curr Opin Rheumatol; 2011 Nov; 23(6):574-8. PubMed ID: 21885973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytoplasmic 5'-nucleotidase autoantibodies in inclusion body myositis: Isotypes and diagnostic utility.
    Greenberg SA
    Muscle Nerve; 2014 Oct; 50(4):488-92. PubMed ID: 24752512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pattern of muscle involvement in inclusion body myositis: a sonographic study.
    Albayda J; Christopher-Stine L; Bingham Iii CO; Paik JJ; Tiniakou E; Billings S; Uy OM; Burlina P
    Clin Exp Rheumatol; 2018; 36(6):996-1002. PubMed ID: 29745890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel serology testing for sporadic inclusion body myositis: disease-specificity and diagnostic utility.
    Herbert MK; Pruijn GJ
    Curr Opin Rheumatol; 2015 Nov; 27(6):595-600. PubMed ID: 26285103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Musculoskeletal Ultrasound in Inclusion Body Myositis: A Comparative Study with Magnetic Resonance Imaging.
    Guimaraes JB; Cavalcante WCP; Cruz IAN; Nico MA; Filho AGO; da Silva AMS; Zanoteli E
    Ultrasound Med Biol; 2021 Aug; 47(8):2186-2192. PubMed ID: 34049727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in serological diagnostics of inflammatory myopathies.
    Benveniste O; Stenzel W; Allenbach Y
    Curr Opin Neurol; 2016 Oct; 29(5):662-73. PubMed ID: 27538058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inclusion body myositis: evolving concepts.
    Perez-Rosendahl M; Mozaffar T
    Curr Opin Neurol; 2022 Oct; 35(5):604-610. PubMed ID: 36069417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel therapeutic approaches for inclusion body myositis.
    Lloyd TE
    Curr Opin Rheumatol; 2010 Nov; 22(6):658-64. PubMed ID: 20827206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 272nd ENMC international workshop: 10 Years of progress - revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16-18 June 2023, Hoofddorp, The Netherlands.
    Lilleker JB; Naddaf E; Saris CGJ; Schmidt J; de Visser M; Weihl CC;
    Neuromuscul Disord; 2024 Apr; 37():36-51. PubMed ID: 38522330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis. Studies in three families.
    Sivakumar K; Semino-Mora C; Dalakas MC
    Brain; 1997 Apr; 120 ( Pt 4)():653-61. PubMed ID: 9153127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
    Lazarou IN; Guerne PA
    J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscle Sonography in Inclusion Body Myositis: A Systematic Review and Meta-Analysis of 944 Measurements.
    Abdelnaby R; Mohamed KA; Elgenidy A; Sonbol YT; Bedewy MM; Aboutaleb AM; Ebrahim MA; Maallem I; Dardeer KT; Heikal HA; Gawish HM; Zschüntzsch J
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.
    Pluk H; van Hoeve BJ; van Dooren SH; Stammen-Vogelzangs J; van der Heijden A; Schelhaas HJ; Verbeek MM; Badrising UA; Arnardottir S; Gheorghe K; Lundberg IE; Boelens WC; van Engelen BG; Pruijn GJ
    Ann Neurol; 2013 Mar; 73(3):397-407. PubMed ID: 23460448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inclusion body myositis: diagnosis, pathogenesis, and treatment options.
    Solorzano GE; Phillips LH
    Rheum Dis Clin North Am; 2011 May; 37(2):173-83, v. PubMed ID: 21444018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging beyond muscle magnetic resonance imaging in inclusion body myositis.
    Goyal NA; Mozaffar T; Dimachkie MM
    Clin Exp Rheumatol; 2023 Mar; 41(2):386-392. PubMed ID: 36700664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrasting echogenicity in flexor digitorum profundus-flexor carpi ulnaris: a diagnostic ultrasound pattern in sporadic inclusion body myositis.
    Noto Y; Shiga K; Tsuji Y; Kondo M; Tokuda T; Mizuno T; Nakagawa M
    Muscle Nerve; 2014 May; 49(5):745-8. PubMed ID: 24037920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.